drugset / Trial / NCT06840899

CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury

NCT06840899

Phase 2 Recruiting 20 enrolled University of Wisconsin, Madison
NaSingle-groupOpen-labelTreatment

Summary

The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI). Participants will take Epidiolex (purified CBD) for 90 days

Timeline

Start
2026-02-13
Primary completion
2027-05
Completion
2027-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 100 mg

Indications